参考文献/References:
[1] 徐飚,成君.加强结核病实施性研究,促进“终止结核病”目标实现[J].中国防痨杂志,2017,39(5):433-434. XU Biao,CHENG Jun.Strengthen TB implementation research and promote the achievement of the goal of “ending TB”[J].Chinese Journal of Antituberculosis,2017,39(5):433-434.
[2] 王旭阳,刘其会,张文宏.精准医疗与结核病[J].微生物与感染,2017,12(6):328-332. WANG Xuyang,LIU Qihui,ZHANG Wenhong.Precision medicine and tuberculosis[J].Journal of Microbes and Infections,2017,12(6):328-332.
[3] 张燕,李波.GeneXpert MTB/RIF快速检测法结核分枝菌及其对利福平耐药性的临床价值评估[J].现代实用医学,2016,28(10):1361-1362. ZHANG Yan,LI Bo.GeneXpert MTB/RIF rapid detection of Mycobacterium tuberculosis and its clinical value of rifampicin resistance[J].Modern Practical Medicine,2016,28(10):1361-1362.
[4] 廖兵,丁显平.T-SPOT.TB 和 ADA 在结核性胸膜炎中的诊断价值[J].国际检验医学杂志,2014,37(17):2323-2325. LIAO Bing,DING Xianping.The diagnostic value of T-SPOT.TB and ADA for tuberculous pleurisy[J].International Journal of Laboratory Medicine,2014,37(17):2323-2325.
[5] 陈效友.《结核病分类》与《肺结核诊断》卫生行业新标准中关于结核性胸膜炎的解析[J].中国防痨杂志,2018,40(3):239-242. CHEN Xiaoyou.Interpreation of newhealth industry standardsdiagnotic cretia for tuberculosis pleurisy[J].Chinese Journal of Antituberculosis,2018,40(3):239-242.
[6] 陈敏,陈杰,宋大伟.三种检测技术联用在结核性胸膜炎诊断中的应用价值[J].中国防痨杂志,2016,38(8):634-638. CHEN Min,CHEN Jie,SONG Dawei.Value of combined use of three testsin diagnosis of tuberculous pleurisy[J].Chinese Journal of Antituberculosis,2016,38(8):634-638.
[7] Chiwala Gift.Elucidating the role of Lactobacillus rhamnosus GG in the prevention of Mycobacterium tuberculosis infection[D].Dalian:Dalian Medical University,2016.
[8] 中华人民共和国国家卫生和计划生育委员会.WS196-2017结核病分类[J].北京:中国标准出版社,2018. National Health and Family Planning Commission of PRC.WS196-2017.Classification of tuberculosis[J].Beijing:Chinese Standards Press,2018.
[9] 杨新宇,易俊莉,邢青,等.881例疑似耐多药肺结核患者的耐药性分析[J].中国防痨杂志,2018,40(2):183-188. YANG Xinyu,YI Junli,XING Qing,et al.Analysis of drug susceptibility testing results of 881 patients with suspected multidrug-resistant pulmonary tuberculosis[J].Chinese Journal of Antituberculosis,2018,40(2):183-188.
[10] 王俊,戴亚新,刘君,等.胸腔积液γ干扰素特异性效应T细胞检测对结核性胸膜炎诊断的价值评估[J].中国实验诊断学,2018,22(3):430-432.WANG Jun,DAI Yaxin,LIU Jun,et al.Assessment of the diagnosed value ofan ELISPOT assay from pleural fluid for tuberculous pleurisy[J].Chinese Journal of Laboratory Diagnosis,2018,22(3):430-432.
[11] 孙朝花,张设,陈银松,等.三项指标联合检测对结核性胸膜炎的诊断价值[J].中国现代医药杂志,2018,20(5):76-78.SUN Chaohua,ZHANG She,CHEN Yinsong,et al.The diagnostic value of combined detection of three indexes in tuberculous pleurisy[J].Modern Medicine Journal of China,2018,20(5):76-78.
[12] 段爱云.结核分枝杆菌T细胞斑点试验技术在结核性胸膜炎诊断中的价值分析[J].中国处方药,2018,16(5):7-8.DUAN Aiyun.Diagnostic value of Mycobacterium tuberculosis T cell spot test(T-SPOT.TB)in the diagnosis of tuberculous pleurisy[J].Journal of China Prescription Drug,2018,16(5):7-8.
[13] 孙海柏,张丽霞,刘佳庆,等.XpertMTB/RIF联合T-SPOT.TB对结核性胸膜炎及其耐药性的临床研究[J].中国现代医学杂志,2018,28(11):93-97.SUN Haibai,ZHANG Lixia,LIU Jiaqing,et al.Clinical role of XpertMTB/RIFcombined with T-SPOT.TB in diagnosis of tuberculous pleurisy and evaluation of drug resistance[J].China Journal of Modern Medicine,2018,28(11):93-97.
[14] 李明.外周血和胸腔积液检测在结核性胸腔积液诊断中的临床应用评价[J].中国处方药,2018,16(4):114-115.LI Ming.Evaluation of clinical application of peripheral blood and pleural effusion detection in diagnosis of tuberculous pleural effusion[J].Journalof China Prescription Drug,2018,16(4):114-115.
[15] 邵吉宝,王相栋,夏睿,等.T-SPOT.TB,TB-Ab和TB-DNA在肺结核与非结核分枝杆菌肺病鉴别诊断中的价值研究[J].现代检验医学杂志,2018,33(4):104-106,111.SHAO Jibao,WANG Xiangdong,XIA Rui,et al.Va-lue of T-SPOT.TB,TB-ABand TB-DNA in differential diagnosis of pulmonary tuberculosis and non-tuberculosi Mycobactera pulmonary disease[J].Journal of Modern Laboratory Medicine,2018,33(4):104-106,111.
[16] 唐冠军,张艳丽.联合检测胸腔积液ADA,IL-27,T-SPOT TB对结核性胸膜炎的诊断价值[J].中外医疗,2018,37(6):28-30.TANG Guanjun,ZHANG Yanli.Combined detection of pleural effusion ADA,IL-27 and T-SPOT TB for the diagnosis of tuberculous pleurisy[J].China & Foreign Medical Treatment,2018,37(6):28-30.